JP2022502429A5 - - Google Patents
Info
- Publication number
- JP2022502429A5 JP2022502429A5 JP2021517252A JP2021517252A JP2022502429A5 JP 2022502429 A5 JP2022502429 A5 JP 2022502429A5 JP 2021517252 A JP2021517252 A JP 2021517252A JP 2021517252 A JP2021517252 A JP 2021517252A JP 2022502429 A5 JP2022502429 A5 JP 2022502429A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- ketamine
- dose
- sequences
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18461615.9 | 2018-09-28 | ||
| EP18461615.9A EP3628313B1 (en) | 2018-09-28 | 2018-09-28 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
| PCT/EP2019/075735 WO2020064748A1 (en) | 2018-09-28 | 2019-09-24 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022502429A JP2022502429A (ja) | 2022-01-11 |
| JP2022502429A5 true JP2022502429A5 (https=) | 2022-09-28 |
| JPWO2020064748A5 JPWO2020064748A5 (https=) | 2022-09-28 |
| JP7444864B2 JP7444864B2 (ja) | 2024-03-06 |
Family
ID=63713806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517252A Active JP7444864B2 (ja) | 2018-09-28 | 2019-09-24 | 肺投与によるうつ病の処置方法における使用のためのケタミン組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11925607B2 (https=) |
| EP (3) | EP3628313B1 (https=) |
| JP (1) | JP7444864B2 (https=) |
| KR (1) | KR102867739B1 (https=) |
| CN (1) | CN113038941A (https=) |
| AU (1) | AU2019349624B2 (https=) |
| BR (1) | BR112021005687A2 (https=) |
| CA (1) | CA3114325A1 (https=) |
| EA (1) | EA202190724A1 (https=) |
| ES (2) | ES3021221T3 (https=) |
| HU (2) | HUE071303T2 (https=) |
| MX (1) | MX2021003668A (https=) |
| PL (2) | PL3628313T3 (https=) |
| WO (1) | WO2020064748A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3505157T3 (pl) | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| GB0523031D0 (en) * | 2005-11-11 | 2005-12-21 | Yaupon Therapeutics | Enhancement of morphine analgesia by s(-)-norketamine |
| WO2007111880A2 (en) | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| DE102007009888A1 (de) | 2007-02-28 | 2008-09-04 | Hermann, Holger Lars, Dr. | Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| PE20141906A1 (es) | 2012-03-12 | 2014-12-05 | Janssen Pharmaceutica Nv | Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento |
| WO2014020155A1 (en) | 2012-08-02 | 2014-02-06 | Clinpharm Reform Gmbh | Oral transmucosal adminstration forms of s-ketamine |
| PE20200404A1 (es) | 2013-03-15 | 2020-02-26 | Janssen Pharmaceutica Nv | Composicion farmaceutica de clorhidrato de s-ketamina |
| CN116251084A (zh) | 2013-03-15 | 2023-06-13 | 詹森药业有限公司 | S-盐酸氯胺酮的药物组合物 |
| CN106714789A (zh) * | 2014-08-13 | 2017-05-24 | 詹森药业有限公司 | 用于治疗抑郁症的方法 |
| US20160338977A1 (en) * | 2015-05-20 | 2016-11-24 | Janssen Pharmaceutica Nv | Methods and kits for treating depression |
| CN106562952B (zh) * | 2015-10-09 | 2020-06-09 | 江阴安博生物医药有限公司 | 氯胺酮在治疗重性抑郁障碍中的应用 |
| PL3505157T3 (pl) * | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
-
2018
- 2018-09-28 EP EP18461615.9A patent/EP3628313B1/en active Active
- 2018-09-28 ES ES18461615T patent/ES3021221T3/es active Active
- 2018-09-28 PL PL18461615.9T patent/PL3628313T3/pl unknown
- 2018-09-28 HU HUE18461615A patent/HUE071303T2/hu unknown
-
2019
- 2019-09-24 EA EA202190724A patent/EA202190724A1/ru unknown
- 2019-09-24 PL PL19770131.1T patent/PL3856159T3/pl unknown
- 2019-09-24 US US17/281,136 patent/US11925607B2/en active Active
- 2019-09-24 BR BR112021005687-4A patent/BR112021005687A2/pt unknown
- 2019-09-24 EP EP19770131.1A patent/EP3856159B1/en active Active
- 2019-09-24 EP EP25162744.4A patent/EP4578505A3/en active Pending
- 2019-09-24 CA CA3114325A patent/CA3114325A1/en active Pending
- 2019-09-24 CN CN201980075601.XA patent/CN113038941A/zh active Pending
- 2019-09-24 ES ES19770131T patent/ES3028459T3/es active Active
- 2019-09-24 WO PCT/EP2019/075735 patent/WO2020064748A1/en not_active Ceased
- 2019-09-24 JP JP2021517252A patent/JP7444864B2/ja active Active
- 2019-09-24 MX MX2021003668A patent/MX2021003668A/es unknown
- 2019-09-24 KR KR1020217011554A patent/KR102867739B1/ko active Active
- 2019-09-24 HU HUE19770131A patent/HUE071649T2/hu unknown
- 2019-09-24 AU AU2019349624A patent/AU2019349624B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2025204271A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| ES2979060T3 (es) | Combinaciones de un antagonista de receptores muscarínicos y un agonista de receptores adrenérgicos beta-2 | |
| JP2023036678A5 (https=) | ||
| JP2021510682A5 (https=) | ||
| JP2018528966A5 (https=) | ||
| ES2613754T3 (es) | Uso de glicopirrolato para tratar la taquicardia | |
| EA201591869A1 (ru) | Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой | |
| NZ606548A (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| RU2006112589A (ru) | Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции | |
| JP2011513451A5 (https=) | ||
| HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
| RU2016117764A (ru) | Рапамицин для лечения лимфангиолейомиоматоза | |
| CA2838030A1 (en) | Combination comprising umeclidinium and a corticosteroid | |
| FI3412277T3 (fi) | Kortikosteroidia ja beeta-adrenergista ainetta käsittävä kuivajauheformulaatio annettavaksi inhalaatiolla | |
| SE527190C2 (sv) | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid | |
| MX2017004476A (es) | Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion. | |
| JP2013507429A5 (https=) | ||
| WO2013104892A1 (en) | Application of high dose compounds via inhalation | |
| HRP20120286T1 (hr) | Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti | |
| JP2022502429A5 (https=) | ||
| CA2838031A1 (en) | Dry powder inhaler compositions comprising umeclidinium | |
| JP5501451B2 (ja) | 咳の治療のためのテオブロミン | |
| JP2015120758A5 (https=) | ||
| SE527200C2 (sv) | Inhalatoranordning samt kombinerade doser av formaterol och fluticason | |
| MX2020007745A (es) | Administracion de dosis elevadas de terapias inhaladas. |